Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yiqilishui Formula on Sepsis Induced Myocardial Dysfunction
NCT06686355Phase 2Recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Nov 2024
- Primary completion
- Dec 2026
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of Yiqilishui formula in myocardial dysfunction, sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Started Nov 2024; status: recruiting.
02
Drugs
Yiqilishui formula
03
Conditions
myocardial dysfunction
Beyond the preview
Go deeper on NCT06686355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06686355.